NASDAQ NMS - GLOBAL MARKET · ADIL
+5.26% · +$0.2000 · Vol 81.1K
Live · updated 15:15:39 ET
Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc

Pharmaceuticals
$4.00
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
ADIL
Adial Pharmaceuticals Inc
Tue Aug 4 · last completed session · daily score · 21h old
STRONG

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

91/ 100
Veridion Score
STRONG · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Tue Aug 4 · last completed session · daily score · 21h old
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ADIL moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ADIL catalysts
About Adial Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2018
Employees
6
Country
US

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$3.75
Day high
$4.20
Day low
$3.75
Previous close
$3.80
52W high
$10.85
-63.13% from high
52W low
$1.36
28% of range
Market cap
$8.3M
EPS
$-2.2800
Beta
1.21
Shares out
2.2M
Volume
81.1K
1.48× rel vol
Avg volume
54.7K
VWAP
$4.03
Price history computed in-house
1W
+26.98%
1M
+37.93%
3M
+181.69%
1Y
-63.13%
YTD
-27.27%
SMA 50 $2.70 · above
SMA 200 $4.09 · below
52W position 28%

ADIL overview

Veridion Score
91
6 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ADIL.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ADIL Form 4 filings
Public disclosures

Congress activity in ADIL

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ADIL in the cached public ledger.

Federal contracts

ADIL contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ADIL in this window.
Lobbying spend

ADIL lobbying filings, year to date.

Registered lobbying filings matched to Adial Pharmaceuticals Inc.

$30.0K
Refresh interval: 12hSource: LDA disclosure filings
Health Issues DefenseHealth Issues
Filing
$10.0K
ADIAL PHARMACEUTICALS INC.

RK STRATEGIES, INC.

Jul 18, 2026
Filing
$10.0K
ADIAL PHARMACEUTICALS INC.

RK STRATEGIES, INC.

Apr 20, 2026
Filing
$10.0K
ADIAL PHARMACEUTICALS INC.

RK STRATEGIES, INC.

Jan 20, 2026
Loading news for ADIL
Analyst ratings
Sovereign unlock shows live analyst consensus for ADIL.
Options
Sovereign unlock shows live options positioning for ADIL.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.